Try our Advanced Search for more refined results
Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Brown & Connery
- Bielli & Klauder
- Tarter Krinsky
- Teitelbaum Law Group
- Hagens Berman
- Simmons Hanly
- Debevoise & Plimpton
- Godfrey & Kahn
- Motley Rice
- Himes Petrarca
- Wachtell Lipton
- Hurwitz Fine
- Gilbert LLP
- BatesCarey
- Lowe Stein
- Archer & Greiner
- Katsky Korins
- Brown Rudnick
- Gage Spencer & Fleming
- FBT Gibbons
- Pashman Stein
- Goodwin Procter
- Doster Ullom
- Crowell & Moring
- Morgan Lewis
- Reed Smith
- McDermott Will & Schulte
- Gertz & Rosen
- Porteous Hainkel
- Andrews & Thornton
- ArentFox Schiff
- Dentons
- Faegre Drinker
- Duane Morris
- Foley & Lardner
- Jones Day
- Davis Polk
- Porter Hedges
- Willkie Farr
- Bentley & Bruning
- ASK LLP
- Hogan Lovells
- Joseph Hage
- Marino Tortorella
- White & Case
- UB Greensfelder
- HSF Kramer
- Seyfarth Shaw
- Spangenberg Shibley
- Cuneo Gilbert
- MoloLamken
- Mintz Levin
- WestLoop Law
- Miller Nash LLP
- Blank Rome
- Kirkland & Ellis
- Cronin Fried
- Loeb & Loeb
- Phillips Lytle
- Arnold & Porter
- Slevin & Hart
- Troutman
- Doshi Legal Group
- Plevin & Turner
- Schenck Price
- Lerner Arnold
- Bialson Bergen
- Martin S. Rapaport
- Skadden Arps
- Saul Ewing
- Taft Stettinius
- Burke Warren
- Wilk Auslander
- Stutzman Bromberg
- Shook Hardy
- Sherrard Roe
- Consovoy McCarthy
- Cleary Gottlieb
- Napoli Shkolnik
- McGrail & Bensinger
- Marcus & Shapira
- Quinn Emanuel
- Pachulski Stang
- King & Spalding
- Potter Anderson
- Stevens & Lee
- Shafferman & Feldman
- Squire Patton
- Blitman & King
- Hughes Socol
- Pillsbury Winthrop
- Robins Kaplan
- WilmerHale
- Keller Rohrback
- Kobre & Kim
- Ballard Spahr
- O'Melveny & Myers
- Keller Postman
- Kleinberg Kaplan
- Clifford Law Offices
- Barack Ferrazzano
- Terrell Hogan
- Levenfeld Pearlstein
- Rothstein Mandell
- MacElree Harvey
- Klehr Harrison
- Pullman & Comley
- Mehri & Skalet
- Tate Law Group LLC
- Lowey Dannenberg
- Williams Mullen
- Waldrep Wall
- Dechert LLP
- Ifrah Law
- Seward & Kissel
- Calfee Halter
- White Coleman & Associates
- Caplin & Drysdale
- Miller Shah
- O'Brien Belland
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- Milbank LLP
Companies
- Teamsters Local 456
- Henry Schein Inc.
- Cencora Inc.
- Hikma Pharmaceuticals PLC
- Giant Eagle Inc.
- McKesson Corp.
- Otis Worldwide Corp.
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- Aleutian Pribilof Islands Association Inc.
- Collegium Pharmaceutical Inc.
- Endo International PLC
- Impax Laboratories, Inc.
- Omnicare Inc.
- Johnson & Johnson
- FTI Consulting Inc.
- Bausch Health Cos. Inc.
- Province LLC
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- DuPont de Nemours Inc.
- Hain Capital Group LLC
- United Parcel Service Inc.
- Express Scripts Holding Co.
- CVS Health Corp.
- KVK Tech Inc.
- Ironshore Inc.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Loblaw Cos.
- Tucson Medical Center
- TR Capital Management LLC
- The Cigna Group
- Viatris Inc.
- Noramco Inc.
- Alaska Native Tribal Health Consortium
- AlixPartners LLP
- Anda Inc.
- Walmart Inc.
- AXA XL Ltd.
- Allergan PLC
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Old Republic Insurance Co.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- State of Nevada
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- Tennessee Attorney General's Office
- Pala Band of Mission Indians
- Seldovia Village Tribe
- Nez Perce Tribe
- Town of Ramapo, New York
- Jamestown S'Klallam Tribe
- St. Regis Mohawk Tribe
- State of Indiana
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- Colorado Attorney General's Office
- Port Gamble S'Klallam Tribe
- U.S. District Court for the District of Columbia
- Borough of Paramus, New Jersey
- Northwestern Band of the Shoshone Nation
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Commonwealth of Massachusetts
- Hopi Tribe
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
February 17, 2026
Food52 Can Sell Assets, Saks Can Close 9 Stores
A Delaware bankruptcy judge approved an agreement on the sale of some of e-commerce company Food52 Inc.'s assets to America's Test Kitchen, a Texas judge allowed Saks Global to start closing nine stores, and a New Jersey judge put the retail operator of outdoor clothing brand Eddie Bauer on track for a March auction.
-
February 12, 2026
Purdue Pharma Judge Declines To Stay Chapter 11 Plan
A New York bankruptcy judge on Thursday denied motions by personal injury claimants in the Purdue Pharma LP case to stay the opioid maker's Chapter 11 plan, ruling that delaying the deal would be far too costly given the movants are not likely to succeed in an appeal.
-
December 18, 2025
Purdue Mediator Says Failure Was Not An Option, Part 2
Former bankruptcy Judge Shelley C. Chapman mediated a $7.4 billion settlement in the Chapter 11 case of Purdue Pharma that received court approval last month. She spoke with Law360 about the pressure she faced to reach a deal and the 18-hour mediation sessions that came with renewed negotiations after the U.S. Supreme Court threw out a critical element of the agreement. She also discussed the role of nonmonetary relief for creditors, including the removal of the Sackler name from buildings and institutions.
-
December 17, 2025
Purdue Ch. 11 Mediator Says Settlement Took A Village, Part 1
Former U.S. Bankruptcy Judge Shelley C. Chapman oversaw the most complex mediation she has seen to date as she guided settlement negotiations in the Chapter 11 case of OxyContin maker Purdue Pharma, and those efforts resulted in a $7.4 billion deal confirmed by a New York court last month.
-
November 24, 2025
Judge Explains OK For Purdue Ch. 11, Yellow Plan Confirmed
A judge provided his reasons for approving Purdue's revised Chapter 11 plan, and Yellow Corp. and business internet service provider Everstream Solutions both obtained confirmation for their bankruptcy plans.
-
November 18, 2025
Purdue's $7.4B Ch. 11 Plan Jibes With New Release Paradigm
A New York bankruptcy judge gave a bench ruling Tuesday explaining his decision to confirm Purdue's $7.4 billion Chapter 11 plan, which transforms the pharmaceutical giant into a public benefit company, ruling that liability releases fully comply with new restrictions imposed by the U.S. Supreme Court last year.
-
November 17, 2025
Purdue, Sunnova Score Approvals For Ch. 11 Plans
Purdue Pharma secured a judge's approval of its new bankruptcy plan. The U.S. Supreme Court won't review a ruling regarding the Serta Simmons Chapter 11 plan. And solar panel company Sunnova also got a court's permission to implement a bankruptcy plan.
-
November 14, 2025
Purdue's $7.4B Ch. 11 Plan To Be Confirmed
A New York bankruptcy judge agreed to confirm the $7.4 billion Chapter 11 plan of Purdue Pharma LP on Friday, saying he would issue a formal bench ruling next Tuesday explaining his decision.
-
November 13, 2025
Objecting Claimants Have Their Say On Purdue Ch. 11 Plan
A New York bankruptcy judge heard statements from more than a dozen opioid personal injury claimants objecting to the Chapter 11 plan of OxyContin maker Purdue Pharma Thursday as the pro se objectors shared concerns about their recoveries, the lack of criminal prosecution of the company's owners and faults in the system that allowed the opioid crisis to occur in the first place.
-
November 12, 2025
Purdue Kicks Off Ch. 11 Confirmation With Plan Overview
Bankrupt OxyContin maker Purdue Pharma began its Chapter 11 confirmation trial Wednesday with an overview of its latest plan and the myriad settlements that underpin the proposal, including a $6.5 billion commitment from the company's owners.